top of page

Monoclonal Antibody Discovery & Antibody Development

We develop novel monoclonal antibodies for the pharmaceutical industry and academia as highly specialized therapeutics, diagnostics, or impactful research tools in biomedical research.

MABY is a spin-off company from the Biomedical Sciences Research Center (BSRC) “A. Fleming” 

UNIQUE BUSINESS MODEL

Intellectual Property Protection

DIVERSE ANTIBODIES

Customized to Work in Your Assay

SCIENTIFIC INSIGHTS

Our Founders are Experts in Neuroimmunology & Neurobiology

OUR PARTNERS & COLLABORATORS

UZH.png
BSRC LOGO NEW.png
Yale_SM_logo copy_edited.png
University_Hospital_of_Zürich_logo.PNG
EKPA_edited.jpg
Contact
bottom of page